Cargando…

Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases

OBJECTIVE: To examine the utility of the new Movement Disorder Society (MDS) diagnostic criteria in a large cohort of Parkinson's disease (PD) patients. METHODS: Recently diagnosed (<3.5 years) PD cases fulfilling United Kingdom (UK) brain bank criteria in Tracking Parkinson's, a UK mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Malek, Naveed, Lawton, Michael A., Grosset, Katherine A., Bajaj, Nin, Barker, Roger A., Ben-Shlomo, Yoav, Burn, David J., Foltynie, Tom, Hardy, John, Morris, Huw R., Williams, Nigel M., Wood, Nicholas, Grosset, Donald G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570813/
https://www.ncbi.nlm.nih.gov/pubmed/28431829
http://dx.doi.org/10.1016/j.parkreldis.2017.04.006
_version_ 1783259224516591616
author Malek, Naveed
Lawton, Michael A.
Grosset, Katherine A.
Bajaj, Nin
Barker, Roger A.
Ben-Shlomo, Yoav
Burn, David J.
Foltynie, Tom
Hardy, John
Morris, Huw R.
Williams, Nigel M.
Wood, Nicholas
Grosset, Donald G.
author_facet Malek, Naveed
Lawton, Michael A.
Grosset, Katherine A.
Bajaj, Nin
Barker, Roger A.
Ben-Shlomo, Yoav
Burn, David J.
Foltynie, Tom
Hardy, John
Morris, Huw R.
Williams, Nigel M.
Wood, Nicholas
Grosset, Donald G.
author_sort Malek, Naveed
collection PubMed
description OBJECTIVE: To examine the utility of the new Movement Disorder Society (MDS) diagnostic criteria in a large cohort of Parkinson's disease (PD) patients. METHODS: Recently diagnosed (<3.5 years) PD cases fulfilling United Kingdom (UK) brain bank criteria in Tracking Parkinson's, a UK multicenter prospective natural history study were assessed by retrospective application of the MDS criteria. RESULTS: In 2000 cases, 1835 (91.7%) met MDS criteria for PD, either clinically established (n = 1261, 63.1%) or clinically probable (n = 574, 28.7%), leaving 165 (8.3%) not fulfilling criteria. Clinically established cases were significantly more likely to have limb rest tremor (89.3%), a good l-dopa response (79.5%), and olfactory loss (71.1%), than clinically probable cases (60.6%, 44.4%, and 34.5% respectively), but differences between probable PD and ‘not PD’ cases were less evident. In cases not fulfilling criteria, the mean MDS UPDRS3 score (25.1, SD 13.2) was significantly higher than in probable PD (22.3, SD 12.7, p = 0.016) but not established PD (22.9, SD 12.0, p = 0.066). The l-dopa equivalent daily dose of 341 mg (SD 261) in non-PD cases was significantly higher than in probable PD (250 mg, SD 214, p < 0.001) and established PD (308 mg, SD 199, p = 0.025). After 30 months' follow-up, 89.5% of clinically established cases at baseline remained as PD (established/probable), and 86.9% of those categorized as clinically probable at baseline remained as PD (established/probable). Cases not fulfilling PD criteria had more severe parkinsonism, in particular relating to postural instability, gait problems, and cognitive impairment. CONCLUSION: Over 90% of cases clinically diagnosed as early PD fulfilled the MDS criteria for PD. Those not fulfilling criteria may have an atypical parkinsonian disorder or secondary parkinsonism that is not correctly identified by the UK Brain Bank criteria, but possibly by the new criteria.
format Online
Article
Text
id pubmed-5570813
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-55708132017-08-30 Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases Malek, Naveed Lawton, Michael A. Grosset, Katherine A. Bajaj, Nin Barker, Roger A. Ben-Shlomo, Yoav Burn, David J. Foltynie, Tom Hardy, John Morris, Huw R. Williams, Nigel M. Wood, Nicholas Grosset, Donald G. Parkinsonism Relat Disord Article OBJECTIVE: To examine the utility of the new Movement Disorder Society (MDS) diagnostic criteria in a large cohort of Parkinson's disease (PD) patients. METHODS: Recently diagnosed (<3.5 years) PD cases fulfilling United Kingdom (UK) brain bank criteria in Tracking Parkinson's, a UK multicenter prospective natural history study were assessed by retrospective application of the MDS criteria. RESULTS: In 2000 cases, 1835 (91.7%) met MDS criteria for PD, either clinically established (n = 1261, 63.1%) or clinically probable (n = 574, 28.7%), leaving 165 (8.3%) not fulfilling criteria. Clinically established cases were significantly more likely to have limb rest tremor (89.3%), a good l-dopa response (79.5%), and olfactory loss (71.1%), than clinically probable cases (60.6%, 44.4%, and 34.5% respectively), but differences between probable PD and ‘not PD’ cases were less evident. In cases not fulfilling criteria, the mean MDS UPDRS3 score (25.1, SD 13.2) was significantly higher than in probable PD (22.3, SD 12.7, p = 0.016) but not established PD (22.9, SD 12.0, p = 0.066). The l-dopa equivalent daily dose of 341 mg (SD 261) in non-PD cases was significantly higher than in probable PD (250 mg, SD 214, p < 0.001) and established PD (308 mg, SD 199, p = 0.025). After 30 months' follow-up, 89.5% of clinically established cases at baseline remained as PD (established/probable), and 86.9% of those categorized as clinically probable at baseline remained as PD (established/probable). Cases not fulfilling PD criteria had more severe parkinsonism, in particular relating to postural instability, gait problems, and cognitive impairment. CONCLUSION: Over 90% of cases clinically diagnosed as early PD fulfilled the MDS criteria for PD. Those not fulfilling criteria may have an atypical parkinsonian disorder or secondary parkinsonism that is not correctly identified by the UK Brain Bank criteria, but possibly by the new criteria. Elsevier Science 2017-07 /pmc/articles/PMC5570813/ /pubmed/28431829 http://dx.doi.org/10.1016/j.parkreldis.2017.04.006 Text en Crown Copyright © 2017 Published by Elsevier Ltd. All rights reserved. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Malek, Naveed
Lawton, Michael A.
Grosset, Katherine A.
Bajaj, Nin
Barker, Roger A.
Ben-Shlomo, Yoav
Burn, David J.
Foltynie, Tom
Hardy, John
Morris, Huw R.
Williams, Nigel M.
Wood, Nicholas
Grosset, Donald G.
Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases
title Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases
title_full Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases
title_fullStr Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases
title_full_unstemmed Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases
title_short Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases
title_sort utility of the new movement disorder society clinical diagnostic criteria for parkinson's disease applied retrospectively in a large cohort study of recent onset cases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570813/
https://www.ncbi.nlm.nih.gov/pubmed/28431829
http://dx.doi.org/10.1016/j.parkreldis.2017.04.006
work_keys_str_mv AT maleknaveed utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases
AT lawtonmichaela utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases
AT grossetkatherinea utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases
AT bajajnin utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases
AT barkerrogera utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases
AT benshlomoyoav utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases
AT burndavidj utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases
AT foltynietom utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases
AT hardyjohn utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases
AT morrishuwr utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases
AT williamsnigelm utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases
AT woodnicholas utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases
AT grossetdonaldg utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases
AT utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases